Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-23

Clinical Trial Update: A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the safety and effectiveness of Ultracet in patients with chronic cancer pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ULTRACET (tramadol hydrochloride/acetaminophen)

Snippet

Sponsor: Janssen-Cilag Ltd.,Thailand | Conditions: Cancer | Phase 4 | Status: COMPLETED